Skip to main content
logo
Nika Pharmaceuticals, Inc. (NIKA)
OTCMKTS · Delayed Price · Currency is USD
0.7690
+0.3250 (73.20%)
At close: Jun 30, 2026

Nika Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-0.08-0.08-0.1-0.06-3.18-0.01
Stock-Based Compensation
----0.15-
Other Operating Activities
---0.04-3-
Change in Other Net Operating Assets
-0-0-0.02---
Operating Cash Flow
-0.08-0.08-0.15-0.06-0.03-0.01
Operating Cash Flow Growth
------

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-0.080.140.080.02-
Long-Term Debt Issued
-----0.01
Total Debt Issued
0.060.080.140.080.020.01
Net Debt Issued (Repaid)
0.060.080.140.080.020.01
Issuance of Common Stock
----0.01-
Financing Cash Flow
0.060.080.140.080.030.01

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-0.02-0-0.020.020-0

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-0.05-0.05-0.08-0.041.15-
Unlevered Free Cash Flow
-0.05-0.05-0.08-0.041.15-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-0-0-0.02---